Physician exposure to and attitudes toward advertisements for genetic tests for inherited cancer susceptibility

American Journal of Medical Genetics

Volumn 135 A, Issue 1, 2005, Pages 41-46

  Vadaparampil, Susan Thomas ^a,e   Wideroff, Louise ^b   Olson, Lorayn ^c   Viswanath, K ^d   Freedman, Andrew N ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c ABT ASSOCIATES   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e LCS FOW   (United States)

Author keywords

Advertising; Genetic testing; Hereditary cancer; Physician specialty; Physician survey

Indexed keywords

ADVERTIZING; ARTICLE; CANCER SUSCEPTIBILITY; CLINICAL PRACTICE; EXPOSURE; FAMILIAL CANCER; GASTROENTEROLOGY; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GYNECOLOGY; MARKETING; MEDICAL DECISION MAKING; MEDICAL SOCIETY; MEDICAL SPECIALIST; OBSTETRICS; ONCOLOGY; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; QUESTIONNAIRE;

ADVERTISING; AMERICAN MEDICAL ASSOCIATION; ATTITUDE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; QUESTIONNAIRES; SPECIALTIES, MEDICAL; UNITED STATES;

EID: 18244408557     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.a.30681     Document Type: Article

References (31)

1. ACOG. 1997. ACOG committee opinion. Breast-ovarian cancer screening. Number 176, October 1996. Committee on Genetics. The American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 56:82-83.
2. AGA. 2001. American Gastroenterological Association medical position statement: Hereditary colorectal cancer and genetic testing. Gastroenterology 12:195-197.
3. Agovino T. 2002. June 06, 2002. Genetic tests to get marketing push. MiamiHerald.Com.
4. ASCO. 1996. Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility, Adopted on February 20, 1996. J Clin Oncol 14:1730-1736; discussion 1737-1740.
5. ASCO. 2003. American Society of Clinical Oncology policy statement update: Genetic testing for cancer susceptibility. J Clin Oncol 21:2397-2406.
6. Burke W, Emery J. 2002. Genetics education for primary-care providers. Nat Rev Genet 3:561-566.
7. Burke W, Acheson L, Botkin J, Bridges K, Davis A, Evans J, Frias J, Hanson J, Kahn N, Kahn R, Lanier D, Pinsky LE, Press N, Lloyd-Puryear MA, Rich E, Stevens N, Thomson E, Wartman S, Wilson M. 2002. Genetics in primary care: A USA faculty development initiative. Community Genet 5:138-146.
8. Caulfield TA. 2001. The informed gatekeeper?: A commentary on genetic tests, marketing pressure, and the role of primary care physicians. Health Law Rev 9:14-18.
9. Culver JO, Hull JL, Dunne DF, Burke W. 2001. Oncologists' opinions on genetic testing for breast and ovarian cancer. Genet Med 3:120-125.
10. Escher M, Sappino AP. 2000. Primary care physicians' knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition. Ann Oncol 11:1131-1135.
11. Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, Gumpper KL, Scholl T, Tavtigian SV, Pruss DR, Critchfield GC. 2002. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: Analysis of 10,000 individuals. J Clin Oncol 20:1480-1490.
12. Freedman AN, Wideroff L, Olson L, Davis W, Klabonde C, Srinath KP, Reeve BB, Croyle RT, Ballard-Barbash R. 2003. US physicians' attitudes toward genetic testing for cancer susceptibility. Am J Med Genet 120A:63-71.
13. Giardiello FM, Brensinger JD, Petersen GM, Luce MC, Hylind LM, Bacon JA, Booker SV, Parker RD, Hamilton SR. 1997. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 336:823-827.
14. Greendale K, Pyeritz RE. 2001. Empowering primary care health professionals in medical genetics: How soon? How fast? How far? Am J Med Genet 106:223-232.
15. Gruppen LD. 1990. Physician information seeking: Improving relevance through research. Bull Med Libr Assoc 78:165-172.
16. Guldal D, Semin S. 2000. The influences of drug companies' advertising programs on physicians. Int J Health Serv 30:585-595.
17. Gutknecht DR. 2001. Evidence-based advertising? A survey of four major journals. J Am Board Fam Pract 14:197-200.
18. Hunter A, Wright P, Cappelli M, Kasaboski A, Surh L. 1998. Physician knowledge and attitudes toward molecular genetic (DNA) testing of their patients. Clin Genet 53:447-455.
19. Jacobellis J, Martin L, Engel J, VanEenwyk J, Bradley L, Kassim S, Jorgenson C, Litch J, Myers M. 2004. Genetic testing for breast and ovarian cancer susceptibility: Evaluating directto-consumer marketing-Atlanta, Denver, Raleigh-Durham, and Seattle, 2003. MMWR Morb Mortal Wkly Rep 53:603-606.
20. Lindor NM, Greene MH. 1998. The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. J Natl Cancer Inst 90:1039-1071.
21. Loeben GL, Marteau TM, Wilfond BS. 1998. Mixed messages: Presentation of information in cystic fibrosis-screening pamphlets. Am J Hum Genet 63:1181-1189.
22. Lynch HT, Snyder CL, Lynch JF, Riley BD, Rubinstein WS. 2003. Hereditary breast-ovarian cancer at the bedside: Role of the medical oncologist. J Clin Oncol 21:740-753.
23. McKelvey KD, Jr., Evans JP. 2003. Cancer genetics in primary care. J Nutr 133:3767S-3772S.
24. Menko FH, Wijnen JT, Khan PM, Vasen HF, Oosterwijk MH. 1996. Genetic counseling in hereditary nonpolyposis colorectal cancer. Oncology (Huntingt) 10:71-76; discussion 81-82.
25. Olufunmilayo I, Olopade MD, Fackenthal JD. 2000. Breast cancer genetics. Implications for clinical practice. Hematol Oncol Clin North Am 14:705-725.
26. Pinsky L, Pagon R, Burke W. 2001. Genetics through a primary care lens. West J Med 175:47-50.
27. Shah BV, Barnwell BG, Beiler GS. 1997. SUDAAN user's manual, release 7.5. Research Triangle Park, NC: Research Triangle Institute.
28. Spiller LD, Wymer WW, Jr. 2001. Physicians' perceptions and uses of commercial drug information sources: An examination of pharmaceutical marketing to physicians. Health Mark Q 19:91-106.
29. Taylor MR. 2001. Genetic testing for inherited breast and ovarian cancer syndromes: Important concepts for the primary care physician. Postgrad Med J 77:11-15.
30. TFGT. 1997. Task Force on Genetic Testing. Promoting Safe and Effective Genetic Testing in the United States.
31. Wideroff L, Freedman AN, Olson L, Klabunde CN, Davis W, Srinath KP, Croyle RT, Ballard-Barbash R. 2003. Physician use of genetic testing for cancer susceptibility: Results of a national survey. Cancer Epidemiol Biomarkers Prev 12:295-303.